Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Opportunities and Obstacles for Generic Drugs

February 02, 2018

Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars.

Cambrex Expands API Development at Iowa Facility

February 01, 2018

Cambrex invests in development and laboratory facilities and adds staff.

Bigger is Better in Samsung's Approach to Biomanufacturing

February 01, 2018

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.

A Three-Step Path Toward Combination Product Approval

February 01, 2018

This article describes how to improve the regulatory journey from classification to market clearance for sponsors of medical device combination products.

Hovione Adds New Capsule Filler at Portugal Site

January 25, 2018

Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.

CPhI Report Predicts A Transformative Year for Japan in 2018

January 25, 2018

Growth is expected for the generic drugs and biosimilars sectors, driven by cost pressures on healthcare systems.

Hospitals Launch Their Own Generic Drug Company

January 19, 2018

Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.

GAO Report Calls for FDA to Publicly Announce Guidance on Nonbiological Complex Drugs

January 16, 2018

The US Government Accountability Office released a report stating that FDA should make its plans to release guidance regarding nonbiological complex drugs public.

Eisai Completes Construction of OSD Production Facility in China

January 11, 2018

The company completed its oral solid dose production facility in Suzhou, China.

FDA Commissioner Gottlieb Gives Update on Saline and Amino Acid Shortages

January 05, 2018

FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.